Diagnostic performance of central vein sign for multiple sclerosis with a simplified three-lesion algorithm

Background: Detection of a “central vein sign” (CVS) on FLAIR* magnetic resonance imaging (MRI) is highly specific and sensitive for multiple sclerosis (MS). We evaluated the specificity and sensitivity of simplified CVS algorithms for MS diagnosis. Methods: MRIs from 10 participants with MS without additional comorbidities for MRI white matter abnormalities; 10 with MS and additional comorbidities for white matter abnormalities; 10 with migraine, white matter abnormalities, and no additional comorbidities; and 10 who had previously been erroneously diagnosed with MS were evaluated. 3T MRI T2-FLAIR and T2*-weighted sequences were acquired to create FLAIR* images. Three MS physician reviewers, blinded to diagnosis, evaluated two different algorithms: (1) three lesions pre-selected on FLAIR were subsequently evaluated for CVS on FLAIR*(select3). (2) FLAIR* was evaluated for up to three lesions with CVS (select3*). Results: For select3, average specificity across reviewers for MS was 0.98 and sensitivity 0.52 and a correct prediction of diagnosis demonstrated kappa = 0.29. For select3*, specificity was 0.81, sensitivity was 0.83, and kappa was 0.31. Conclusion: A simplified determination of CVS in three white matter lesions on 3T FLAIR* MRI demonstrated good specificity and sensitivity and fair inter-rater reliability for a diagnosis of MS and with further study, may be a candidate for clinical application.

[1]  D. Reich,et al.  Clinical 3-tesla FLAIR* MRI improves diagnostic accuracy in multiple sclerosis , 2016, Multiple sclerosis.

[2]  M. Freedman,et al.  MS, MRI, and the 2010 McDonald criteria , 2012, Neurology.

[3]  P. Morgan,et al.  Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions , 2016, Multiple sclerosis.

[4]  Roland G. Henry,et al.  The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative , 2016, Nature Reviews Neurology.

[5]  J. Simon,et al.  Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients , 2013, Multiple sclerosis.

[6]  Gregory F. Wu,et al.  The contemporary spectrum of multiple sclerosis misdiagnosis , 2016, Neurology.

[7]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[8]  B. Rasmussen,et al.  Migraine prevalence. A review of population-based studies. , 1994, Neurology.

[9]  Nikos Evangelou,et al.  The Central Vein Sign in Multiple Sclerosis Lesions Is Present Irrespective of the T2* Sequence at 3 T , 2017, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[10]  Jeffrey A. Cohen,et al.  Differential diagnosis of suspected multiple sclerosis: a consensus approach , 2008, Multiple sclerosis.

[11]  Pascal Sati,et al.  FLAIR*: a combined MR contrast technique for visualizing white matter lesions and parenchymal veins. , 2012, Radiology.

[12]  Nikos Evangelou,et al.  Central veins in brain lesions visualized with high-field magnetic resonance imaging: a pathologically specific diagnostic biomarker for inflammatory demyelination in the brain. , 2013, JAMA neurology.

[13]  D. Reich,et al.  “Central vessel sign” on 3T FLAIR* MRI for the differentiation of multiple sclerosis from migraine , 2015, Annals of clinical and translational neurology.

[14]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[15]  Andrew J Solomon,et al.  Misdiagnosis of Multiple Sclerosis: Frequency, Causes, Effects, and Prevention , 2013, Current Neurology and Neuroscience Reports.

[16]  D. Reich,et al.  Rapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosis , 2014, Multiple sclerosis.

[17]  R. Lipton,et al.  Migraine prevalence, disease burden, and the need for preventive therapy , 2007, Neurology.

[18]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[19]  Dennis Bourdette,et al.  “Undiagnosing” multiple sclerosis , 2012, Neurology.